SUMMARY
The aim of this experimental in vivo study was to examine the effect of topically-used gentamicin bound to microdispersed oxidized cellulose (MDOC) in nanofibre form in the treatment of deep surgical site infections and to compare it with Garamycin Schwamm®. Twelve domestic swine were used in a model of a full-thickness infected dermal wound. The effectiveness of both forms of gentamicin were tested in wound infections caused by Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli. The effectiveness of gentamicin-MDOC and Garamycin Schwamm® were comparable according to microbiological culture findings, with no statistically significant differences. When macroscopically assessed, 100% of the infected wounds treated by gentamicin-MDOC were without signs of infection, compared with only 16.7% when Garamycin Schwamm® was used and this was of statistical significance. Therefore when combined with a nanofibre MDOC carrier, topically-used gentamicin is rendered more effective for the treatment of full-thickness skin infections.
KEY WORDS
gentamicin; microdispersed oxidized cellulose; surgical site infections; Garamycin Schwamm
REFERENCES
Bruce J, Russel EM, Mollison J, Krukowski ZM. The measurement and monitoring of surgical adverse events. Health Technol Assess. 5: 1-194, 2001.
Buimer MG, Ankersmit MFP, Wobbes T, Klinkenbijl JHG. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 34: 224-227, 2008.
[CrossRef]
CDC National Nosocomial Infections Surveillance (NNIS). Data summary from October 1986-April 1996, issued May 1996: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control. 24: 380-388, 1996.
[CrossRef]
Diehr S, Hamp A, Jamieson B. Do topical antibiotics improve wound healing? J Fam Pract. 56: 140-144, 2007.
Eklund AM. Prevention of sternal wound infections with locally administered gentamicin. APMIS. 115: 1022-1024, 2007.
[CrossRef]
Eklund AM, Valtonen M, Werkkala KA. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J Hosp Infect. 59: 108-112, 2005.
[CrossRef]
Eveillard M, Mertl P, Tramier B, Eb F. Effectiveness of gentamicin-impregnated cement in the prevention of deep wound infection after primary total knee arthroplasty. Infect Control Hosp Epidemiol. 24: 778-780, 2003.
[CrossRef]
Friberg O: Local collagen-gentamicin for prevention of sternal wound infections: the LOGIP trial. APMIS. 115: 1016-1021, 2007.
[CrossRef]
Friberg O, Jones I, Sjoberg L, Soderquist B, Vikerfors T, Kallman J. Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery. Scand J Infect Dis. 35: 251-254, 2003.
[CrossRef]
Friberg O, Svedjeholm R, Soderquist B, Granfeldt H, Vikerfors T, Kallman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 79: 153-161; discussion 161-162, 2005.
[CrossRef]
Friberg O, Svedjeholm R, Kallman J, Soderquist B. Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis. Eur J Clin Microbiol Infect Dis. 26: 91-97, 2007.
[CrossRef]
Gomez GV, Guerrero TS, Lluck MC, Delgado FJ. Effectiveness of collagen-gentamicin implant for treatment of "dirty" abdominal wounds. World J Surg. 23: 123-127, 1999.
[CrossRef]
Grussner U, Clemens M, Pahlplatz PV, Sperling P, Witte J, Rosen HR. Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer. Am J Surg. 182: 502-509, 2001.
[CrossRef]
Gustafsson U-M, Graf W. Randomized clinical trial of local gentamicin-collagen treatment in advancement flap repair for anal fistula. Br J Surg. 93: 1202-1207, 2006.
[CrossRef]
Haase O, Raue W, Bohm B, Neuss H, Scharfenberg M, Schwenk W. Subcutaneous gentamycin implant to reduce wound infections after loop-ileostomy closure: A randomized double-blind, placebo-controlled trial. Dis Colon Rectum. 48: 2025-2031, 2005.
[CrossRef]
Holzer B, Grussner U, Bruckner B, Houf M, Kiffner E, Schildberg FW, Vogel P, Rosen HR and the EMD study group. Efficacy and tolerance of a new gentamicin collagen fleece (Septocoll®) after surgical treatment of a pilonidal sinus. Colorectal Dis. 5: 222-227, 2003.
[CrossRef]
Kraus SJ, Eron LJ, Bottenfield GW, Drehobl MA, Bushnell WD, Cupo MA. Mupirocin cream is as effective as oral cephalexin in the treatment of secondarily infected wounds. J Fam Pract. 47: 429-433, 1998.
Leyh RG, Bartels C, Sievers H-H. Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann Thorac Surg. 68: 1648-1651, 1999.
[CrossRef]
Musella M, Guido A, Musella S. Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg. 167 :130-132, 2001.
[CrossRef]
Nooyen SM, Overbeek BP, Brutel de la Riviere A, Storm AJ, Langemeyer JM. Prospective randomized comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting. Eur J Clin Microbiol Infect Dis. 13: 1033-1037, 1994.
[CrossRef]
O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg. 88: 4-21, 2001.
[CrossRef]
Plodr M: Local antimicrobial agents for surgical application and comparison of their properties in an infection wound model. Dissertation work. Hradec Kralove: VLA JEP, 2004.
Rosen HR, Marczell AP, Czerwenka E, Stierer MO, Spoula H, Wasl H. Local gentamicin application for perineal wound-healing following abdominoperineal rectum excision. Am J Surg. 162: 438-441, 1992.
[CrossRef]
Schersten H. Modified prophylaxis for preventing deep sternal wound infection after cardiac surgery. APMIS. 115: 1025-1028, 2007.
[CrossRef]
Smyth ETM, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, Davies E, Newcombe RG, Spencer RC and on behalf of the Hospital Infection Society Prevalence Survey Steering Group. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect. 69: 230-248, 2008.
[CrossRef]
|
CITED
Prabhu P, Patravale V, Joshi M. Nanocarriers for Effective Topical Delivery of Anti-Infectives. Curr Nanosci. 8: 491-503, 2012.
|
